Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2880973rdf:typepubmed:Citationlld:pubmed
pubmed-article:2880973lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2880973lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2880973lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:2880973lifeskim:mentionsumls-concept:C0011685lld:lifeskim
pubmed-article:2880973lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:2880973lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:2880973lifeskim:mentionsumls-concept:C0205349lld:lifeskim
pubmed-article:2880973lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:2880973lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:2880973pubmed:issue12lld:pubmed
pubmed-article:2880973pubmed:dateCreated1987-4-1lld:pubmed
pubmed-article:2880973pubmed:abstractTextThe antinociceptive effect of subcutaneous 4,5,6,7-tetrahydroisoxazol[5,4-c]pyridin-3-ol (THIP) or (+/-)-baclofen, measured as reaction time of rats placed on a plate heated to 55 degrees C, was assessed after a single or the last repeated (18 consecutive days) dose (5 mg kg-1 once daily) of subcutaneous desipramine. Baclofen (10 mg kg-1)-induced antinociception was reduced by acute and unaffected by chronic desipramine treatment. On the contrary, THIP (20 mg kg-1)-induced antinociception was unaffected by acute and reduced by chronic desipramine.lld:pubmed
pubmed-article:2880973pubmed:languageenglld:pubmed
pubmed-article:2880973pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2880973pubmed:citationSubsetIMlld:pubmed
pubmed-article:2880973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2880973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2880973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2880973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2880973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2880973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2880973pubmed:statusMEDLINElld:pubmed
pubmed-article:2880973pubmed:monthDeclld:pubmed
pubmed-article:2880973pubmed:issn0022-3573lld:pubmed
pubmed-article:2880973pubmed:authorpubmed-author:MeliAAlld:pubmed
pubmed-article:2880973pubmed:authorpubmed-author:BorsiniFFlld:pubmed
pubmed-article:2880973pubmed:authorpubmed-author:GiulianiSSlld:pubmed
pubmed-article:2880973pubmed:issnTypePrintlld:pubmed
pubmed-article:2880973pubmed:volume38lld:pubmed
pubmed-article:2880973pubmed:ownerNLMlld:pubmed
pubmed-article:2880973pubmed:authorsCompleteYlld:pubmed
pubmed-article:2880973pubmed:pagination934-5lld:pubmed
pubmed-article:2880973pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2880973pubmed:meshHeadingpubmed-meshheading:2880973-...lld:pubmed
pubmed-article:2880973pubmed:meshHeadingpubmed-meshheading:2880973-...lld:pubmed
pubmed-article:2880973pubmed:meshHeadingpubmed-meshheading:2880973-...lld:pubmed
pubmed-article:2880973pubmed:meshHeadingpubmed-meshheading:2880973-...lld:pubmed
pubmed-article:2880973pubmed:meshHeadingpubmed-meshheading:2880973-...lld:pubmed
pubmed-article:2880973pubmed:meshHeadingpubmed-meshheading:2880973-...lld:pubmed
pubmed-article:2880973pubmed:meshHeadingpubmed-meshheading:2880973-...lld:pubmed
pubmed-article:2880973pubmed:meshHeadingpubmed-meshheading:2880973-...lld:pubmed
pubmed-article:2880973pubmed:meshHeadingpubmed-meshheading:2880973-...lld:pubmed
pubmed-article:2880973pubmed:year1986lld:pubmed
pubmed-article:2880973pubmed:articleTitleFunctional evidence for altered activity of GABAergic receptors following chronic desipramine treatment in rats.lld:pubmed
pubmed-article:2880973pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2880973pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2880973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2880973lld:pubmed